36.7 F
New York
Wednesday, December 2, 2020

Akers Biosciences [NASDAQ: AKER] Announces Merger Agreement With MyMD Pharmaceuticals

Must read

Salesforce [NYSE: CRM] Enters A Deal To Acquire Slack

Salesforce engages in a contract to buy Slack at a worth of $27.7B. This purchase to build an operating system for the...

Xilinx [NASDAQ: XLNX] Announced That It Acquired Falcon Computing

Xilinx Inc. declared that it has purchased falcon Computing Solutions to make flexible computing more accessible and easily adapted by computer programmers. The...

Luokung Corp. [NASDAQ: LKCO] To Acquire EMG For RMB 836 Million

Luokung Technologies Corp. a location-based service company has agreed to buy EMG technologies for Ren Min Bi  836 million. The company will pay...

Nokia [NYSE: NOK] Extends Collaboration With AT&T to Deliver Seamless IoT Connectivity

Nokia Corp. declared that the company has extended its contract with AT&T . The collaboration among the companies can supply and provide an...

Akers Biosciences, Inc. [NASDAQ: AKER] has announced today that it has signed a merger agreement with MyMD Pharmaceuticals, Inc. The merged company will be named MyMD Pharmaceuticals and will continue its listing on NASDAQ but with a new ticker symbol “MYMD”.

The two companies’ motive behind this merger is to focus on developing and commercializing novel immunotherapy pipeline assets of MyMD including MYMD-1. MyMD is also planning to develop its second asset, SUPERA-1R.

MYMD-1 is being developed to treat age-related and autoimmune diseases. Additionally, the company has already executed the Phase I study on MYMD-1. It is also planning to launch two Phase II trials. One in Q1 of 2021 and the second one is throughout 2021.

Shares of Akers Biosciences [NASDAQ: AKER] soared 25.62% as it gained +0.44 during the trading session of Thursday. In the past 52-weeks of trading, this company’s stock has changed between the low of $1.55 and a high of $8.85. It has traded up 39.40% from its 52-weeks low and traded down -75.59% from its 52-weeks high.

Turning our focus on its liquidity, it has a current ratio of 6.80 and a quick ratio of 6.80. Akers Biosciences market capitalization has remained high, hitting $14.62 million at the time of writing.

Akers Biosciences and MyMD Pharmaceuticals are intending to hold a video conference call for investors on November 18, 2020. Furthermore, it has been revealed that the integrated company will be led by Chris Chapman, M.D. He will become President and Chief Medical Officer of MyMD.

More articles

Latest article

Wendy [NASDAQ: WEN] Strikes A Deal With Rebel Foods To Open 250 Cloud Kitchens.

Wendy’s Co. and Rebel foods have partnered to open about 250 cloud kitchens in India. These kitchens will only serve the customer with...

Tesla [NASDAQ: TSLA] Recalls 9537 SUV’s Because Of Manufacturing Issues

Tesla Inc. has released safety recall orders for more than 9500 of its vehicle in the United States. The vehicles include Model Xs...

Northrop [NYSE:NOC] awarded a deal of $4.8B for Global Hawk Aircraft

Northrop Gruman Corp. has been awarded a deal to perform development, transformation, retrofit, and sustenance activities for the Global Hawk Program. This deal...

Athene Enters Into An Agreement With Hertz To Buy Donlen Corp.

Athene Holdings ltd. entered into a deal to buy Donlen corporation from Hertz Global Holdings Inc. Hertz's fully own Donlen Corporation. The stock...

Verizon [NYSE: VZ] Announced to acquire Tracfone for $6.25 billion.

Verizon Communication Inc. declared that it penned down a deal with America Movil to purchase Tracfone for $6.25B. The companies came to terms...

ViacomCBS [NASDAQ: VIAC] Agreed To Sell Simon And Schuster For $2.175 Billion In Cash

ViacomCBS Inc. declared that it entered into an agreement with Penguin Random House LCC to sell Simon and Schuster. It will be sold...

IBM [NYSE: IBM] Plans To Cut Down 20% Of Its Workforce

International business machines Corp. declared that the company is preparing to cut down 10,000 jobs in Europe which makes it’s 20% of the...

Ford [NYSE: F ] Booked Ultra-Cold Freezers To Ensure Autoworkers Access To The Covid-19 Vaccine

Ford Motors Co. revealed recently that to stock Pfizer Inc Covid-19 vaccine securely, it has requested 12 of the ultra-cold freezer. The automaker...